Lupus is a chronic autoimmune disease in which your immune system mistakenly attacks your own healthy tissues. It can affect nearly any part of the body, including the joints, skin, kidneys, brain, heart, and lungs. About 9 out of 10 people diagnosed with lupus are women, and symptoms typically appear between the ages of 15 and 45.
How Lupus Works in the Body
In a healthy immune system, white blood cells identify and destroy invaders like bacteria and viruses. In lupus, certain immune cells lose the ability to distinguish between foreign threats and the body’s own tissues. Specifically, a group of immune cells begins producing proteins called autoantibodies that react against the nuclei of your own cells. These autoantibodies, detected through a blood test called ANA (antinuclear antibody), are a hallmark of the disease.
The autoantibodies form clusters with cellular debris and lodge in tissues throughout the body, triggering inflammation. A signaling molecule called type 1 interferon plays a central role, disrupting the normal checkpoints that would ordinarily weed out self-attacking immune cells before they cause harm. This creates a self-reinforcing cycle: more inflammation generates more cellular debris, which produces more autoantibodies, which drives more inflammation.
Four Types of Lupus
Systemic lupus erythematosus (SLE) is the most common and serious form. It can range from mild to life-threatening and may affect the joints, skin, brain, lungs, kidneys, and blood vessels. When people say “lupus” without further specification, they generally mean SLE.
Cutaneous lupus is limited to the skin. The immune system targets skin cells, producing rashes or raised lesions, usually on sun-exposed areas like the face, neck, and arms.
Drug-induced lupus looks similar to SLE but is triggered by an overreaction to certain medications, including some blood pressure drugs, anti-seizure medications, and antibiotics. Symptoms typically appear 3 to 6 months after starting the medication and disappear once it’s stopped.
Neonatal lupus occurs when a developing baby is exposed to the mother’s lupus-related antibodies in the womb. It can cause skin, liver, or blood problems that usually resolve by age 6 months. In rare cases, it leads to congenital heart block, a serious condition that may require a pacemaker.
Common Symptoms and Flare Triggers
Lupus is sometimes called “the great imitator” because its symptoms overlap with many other conditions. The most recognizable sign is a butterfly-shaped rash that spreads across both cheeks and the bridge of the nose. Many people with lupus develop this rash, but not all do. It tends to worsen with sun exposure.
Other common symptoms include:
- Joint pain, stiffness, and swelling
- Persistent fatigue that doesn’t improve with rest
- Fever with no obvious infection
- Skin lesions that appear or worsen in sunlight
- Fingers and toes that turn white or blue in cold temperatures
- Chest pain when breathing deeply
- Hair loss
- Mouth sores
Lupus symptoms come and go in episodes called flares. Three common triggers can set off a flare or worsen existing symptoms. Sunlight is one of the most reliable triggers, causing both skin rashes and systemic symptoms. Infections can activate the immune system in ways that spark a flare. And certain medications can provoke lupus-like reactions even in people who weren’t previously diagnosed.
Who Gets Lupus
Lupus disproportionately affects women, who make up roughly 90% of all cases. It also hits certain ethnic groups harder. Black and American Indian or Alaska Native women are 2 to 3 times more likely than white women to develop the disease. Hispanic and Asian populations are also affected at higher rates than white populations. The reasons likely involve a combination of genetic susceptibility, hormonal factors, and differences in environmental exposures.
Kidney Involvement
One of the most serious complications of lupus is kidney inflammation, known as lupus nephritis. As many as half of adults with lupus develop some degree of kidney disease. The autoantibodies that circulate in the blood can deposit in the tiny filtering units of the kidneys, causing progressive damage.
Early signs include foamy urine (a signal that protein is leaking through damaged kidney filters), swelling in the legs, feet, ankles, or face, and high blood pressure. Because kidney damage can progress silently before symptoms appear, regular urine and blood tests are an important part of lupus management.
How Lupus Is Treated
There is no cure for lupus, but modern treatments have dramatically improved outcomes. The cornerstone of long-term management is hydroxychloroquine, an oral medication that modulates the immune system and helps prevent flares. Most people with lupus take it continuously as a maintenance therapy.
When lupus is first diagnosed or during severe flares, corticosteroids may be used to rapidly reduce inflammation, especially if internal organs are involved. Because long-term steroid use carries significant side effects, doctors typically transition patients to steroid-sparing medications that suppress the immune system through different pathways. These allow the steroids to be tapered down while keeping inflammation controlled.
Two biologic therapies offer more precise treatment options. One targets a protein that activates the immune cells responsible for producing autoantibodies. The other blocks the type 1 interferon receptor, interrupting the signaling molecule that drives much of the inflammatory cycle. These biologics can be combined with other immunosuppressive medications, particularly for treating kidney involvement.
Treatment is highly individualized. Someone with mild joint pain and skin rashes may need only hydroxychloroquine and sun protection, while someone with kidney inflammation may require a combination of several medications.
Survival and Long-Term Outlook
The prognosis for lupus has improved enormously over the past several decades. In the 1960s, only about 72% of people with lupus survived five years after diagnosis. By 2020, that number had risen to roughly 94%. The 10-year survival rate climbed from 58% to about 90% over the same period. Even 20-year survival has reached 84%, up from 59% in the 1990s.
These gains reflect better diagnostic tools, earlier detection, and more effective medications. The biggest threats to long-term health remain kidney damage, cardiovascular disease, and infections related to immune-suppressing treatments. With consistent monitoring and treatment, most people with lupus live full, active lives, though managing the unpredictability of flares remains a daily reality.